SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CLYM

Climb Bio Inc.
NASDAQHealth Care

Latest close: 9.82 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 15, 2026Reported sale · Form 4Stephen Basil Thomas · $1.4MOpen the filing ↗
  2. Sep 15, 2026Notice of sale · Form 144STEPHEN THOMAS · Director · $1.5MOpen the filing ↗
  3. Sep 3, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record28714 flagged findings
Reported transactions (Form 4)80since Jul 11, 2024 · and 4 other holdings
Corporate events (8-K)30since Jan 31, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as ELYM.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-09share offering or dilution eventrecentOpen filing ↗
    “…stockholders pursuant to which we agreed to issue and sell to the selling stockholders an aggregate of 9,481,000 shares of our…”
    +1 more passage from the same document
    • “…equal to $9.50 and, in lieu of common stock to a certain selling stockholder, prefunded warrants to purchase up to an aggregate of…”
  • 2026-05-29share offering or dilution eventrecentOpen filing ↗
    “…stockholders pursuant to which we agreed to issue and sell to the selling stockholders an aggregate of 9,481,000 shares of our…”
    +1 more passage from the same document
    • “…equal to $9.50 and, in lieu of common stock to a certain selling stockholder, prefunded warrants to purchase up to an aggregate of…”
  • 2026-05-07share offering or dilution eventrecentOpen filing ↗
    “…an exchange agreement (the Exchange Agreement) with RA Capital Management, LP (RA Capital Management) and an entity affiliated…”
    +1 more passage from the same document
    • “…Company’s common stock, beneficially owned by the Exchanging Holder for a pre-funded warrant to purchase the same number of shares…”
  • 2026-05-07export control restrictionsrecentOpen filing ↗
    “…or cost-effective basis. In addition, tariffs on pharmaceutical products and ingredients imported from China, as well as potential…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 287)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Sep 15, 26Form 144 ↗Notice of proposed sale
  • Sep 3, 268-K ↗Current report · Communication to the market
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • Aug 14, 268-K ↗Current report · Other events
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 268-K ↗Current report · Results
  • Jul 8, 26SCHEDULE 13G ↗Passive stake · FMR LLC · 11.9% · event on Jun 30, 26
  • Jul 7, 26SCHEDULE 13D/A ↗Stake with intent to influence · RA Capital Management, L.P. · 33.0% · event on Jul 2, 26 · amendment
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Jul 1, 26Form 3 ↗Insider transaction
  • Jul 1, 268-K ↗Current report · A senior executive left or was appointed
  • Jun 30, 26Form 4 ↗Insider transaction
  • Jun 30, 26Form 144 ↗Notice of proposed sale
  • Jun 12, 268-K ↗Current report · Entered a material agreement
  • Jun 12, 26424B5 ↗Securities offering
  • Jun 11, 268-K ↗Current report · Other events
  • Jun 9, 26424B3 ↗Securities offering
  • Insider transaction · 5 Form 4 filingsshow all 5hide

287 filings on record, the oldest from Jun 9, 21.

Listing the 25 most recent filings of the 287 on record.

8-Ks, explained

Stress1Structure12Governance17
  • Jul 1, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 12, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jun 8, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 28, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 3, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 11, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2025show all 4hide
    • Oct 1, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jun 18, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 23, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 1, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 25, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 10, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Aug 27, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 26, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 27, 24StructureEntered a material agreement+6 more in the same filing8-K 1.01 ↗

7 older filings not shown

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Feb 14, 23StressRestructuring plan with committed costs+4 more in the same filing8-K 2.05 ↗

The full record holds 1 stress filing.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • RA Capital Management, L.P.33.0%Jul 2, 26SCHEDULE 13D/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • AI ETI LLC5.7%Oct 3, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • FMR LLC11.9%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Pontifax VI G.P. L.P.7.7%Jun 27, 24SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • MPM BioImpact LLC5.6%Dec 31, 25SCHEDULE 13G ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Sep 15, STEPHEN THOMAS filed notice of intent to sell up to $1.5M. That is about 0.17% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $1.4M on Sep 15, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+1 more recent notices

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 15, 26Sell$1.4MStephen Basil Thomas↗
  • Jun 29, 26Sell$407KAoife BrennanPresident and CEO↗
  • Feb 26, 26Sell$114KStephen Basil Thomas↗
  • Feb 25, 26Sell$236KStephen Basil Thomas↗
  • Feb 13, 26Sell$58KStephen Basil Thomas↗
  • Feb 12, 26Sell$471KStephen Basil Thomas↗
  • Jan 5, 26Buy$25KRA CAPITAL MANAGEMENT, L.P.↗
  • Dec 12, 25Buy$290KRA CAPITAL MANAGEMENT, L.P.↗
  • Dec 11, 25Buy$465KRA CAPITAL MANAGEMENT, L.P.↗
  • Jun 30, 25Sell$25KAoife BrennanPresident and CEO↗
  • Jun 20, 25Sell$2KEmily PimblettSVP, Finance & CAO↗
  • Mar 20, 25Sell$2KEmily PimblettSVP, Finance & CAO↗

There are 13 more transactions in this stretch.

Stock compensation, tax and giftsshow the 15 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 28, 26Compensation$35KRA CAPITAL MANAGEMENT, L.P.↗
  • Sep 28, 26Compensation$30KRA CAPITAL MANAGEMENT, L.P.↗
  • Sep 28, 26Compensation$79KRA CAPITAL MANAGEMENT, L.P.↗
  • Sep 28, 26Compensation$52KRA CAPITAL MANAGEMENT, L.P.↗
  • Jun 27, 26Compensationamount n/aAoife BrennanPresident and CEO↗
  • Dec 11, 25Otheramount n/aRA CAPITAL MANAGEMENT, L.P.↗
  • Aug 7, 25Compensationamount n/aStephen Basil Thomas↗
  • Jun 27, 25Compensationamount n/aStephen Basil Thomas↗
  • Jun 27, 25Compensationamount n/aAoife BrennanPresident and CEO↗
  • Jun 18, 25Compensationamount n/aEmily PimblettSVP, Finance & CAO↗
  • Mar 27, 25Compensationamount n/aStephen Basil Thomas↗
  • Mar 18, 25Compensationamount n/aEmily PimblettSVP, Finance & CAO↗
  • Jan 1, 25Compensationamount n/aStephen Basil Thomas↗
  • Dec 18, 24Compensationamount n/aEmily PimblettCHIEF ACCOUNTING OFFICER↗
  • Sep 18, 24Compensationamount n/aEmily PimblettCHIEF ACCOUNTING OFFICER↗

The full record holds 58 transactions and goes back to Mar 10, 23.

Its sector and its market

Climb Bio Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Climb Bio Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Climb Bio Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
287 documents on file, from Jun 9, 2021 to Sep 30, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.